Syra Health

SYRA · OTC

$0.83+$0.0042 (+0.51%)TodayMarket closed ·
Prev close $0.8258

Latest news

  • Press releasePRNewswire

    Syra Health Awarded Three-Year Public Health Analytics Contract with Mississippi State Department of Health

  • Press releasePRNewswire

    Syra Health, in Partnership with HealthSync, Selected for CMS ACCESS Model, Advancing Long-Term Growth Strategy

  • Press releasePRNewswire

    Syra Health, Wake County Public Health Expand Wellness Partnership

  • News

    Syra Health Q2 EPS $0.02 Up From $(0.01) YoY, Sales $2.394M Up From $1.946M YoY

  • Press releasePRNewswire

    Syra Health Achieves 23% Revenue Growth, Improves Gross Margin to 44.5% in Second Consecutive Profitable Quarter

  • Press releasePRNewswire

    Syra Health To Announce Second Quarter 2026 Financial Results

  • Press releasePRNewswire

    Syra Health Appoints Dr. Cori McMahon as Chief Medical Officer to Support its Growth Strategy

  • News

    Syra Health Q1 EPS $0.02 Up From $(0.04) YoY, Sales $2.274M Up From $1.857M YoY

  • Press releasePRNewswire

    Syra Health Delivers its First Profitable Quarter in Q1 2026, Expands Margins and Strengthens Financial Position

  • Press releasePRNewswire

    Syra Health To Announce First Quarter 2026 Financial Results

  • Press releasePRNewswire

    Syra Health Wins Innovation of the Year and BioCrossroads Life Sciences Innovation Award at the 2026 TechPoint Mira Awards

  • Press releasePRNewswire

    Syra Health and Nora Mental Health Announce Telehealth Partnership to Expand Access to Mental and Behavioral Health Services Across Indiana

  • Press releasePRNewswire

    Syra Health Posts Strong FY2025 Results with 157% Population Health Growth and 76% Net Loss Reduction: Targets Profitability by Year-End 2026

  • Press releasePRNewswire

    Syra Health To Announce Fourth Quarter and Full Year 2025 Financial Results

  • Press releasePRNewswire

    Syra Health Appoints Healthcare Executive and Former U.S. Marine Gregory R. Alexander as Chief Executive Officer to Drive Growth

  • Press releasePRNewswire

    Syra Health Announces Third Quarter Financial Results: Margins, Profitability Metrics Improve

  • Press releasePRNewswire

    Syra Health To Announce Third Quarter 2025 Financial Results

  • Press releasePRNewswire

    Syra Health to Participate in Two Upcoming Indiana Healthcare Conferences

  • Press releasePRNewswire

    Syra Health Announces Second Quarter Financial Results, Advancing Toward Profitability on Margin Gains and Cost Reductions

  • Press releasePRNewswire

    Syra Health To Announce Second Quarter 2025 Financial Results

  • Press releasePRNewswire

    Syra Health Secures Contract Valued at Up to $2.1 Million to Provide Medical Management Nurses for Major Insurance Provider

  • Press releasePRNewswire

    Syra Health Earns ISO 27001:2022 Certification, Highlighting Company's Commitment to Data Protection

  • Press releasePRNewswire

    Syra Health Selected for $5.8 Million Indiana Child Mental Health Program

  • Press releasePRNewswire

    Syra Health Board Begins CEO Search to Drive Growth

  • Press releasePRNewswire

    Syra Health Announces First Quarter Revenue of $1.9 Million, Up 6% YoY

  • Press releasePRNewswire

    Syra Health To Discuss First Quarter 2025 Financial Results

  • News

    12 Health Care Stocks Moving In Wednesday's After-Market Session

  • News

    12 Health Care Stocks Moving In Wednesday's Intraday Session

  • NewsAvi Kapoor

    Gold Moves Higher; US Private Sector Job Growth Tops Estimates

  • NewsAvi Kapoor

    Nasdaq Tumbles 100 Points; UniFirst Posts Upbeat Earnings

  • NewsRishabh Mishra

    US Stock Futures Slip Ahead Of 'Liberation Day' Tariffs Announcement: Expert Points To Uncertainty Amid Higher Risk Premia

  • Press releasePRNewswire

    Syra Health Announces Voluntary Delisting from the Nasdaq Capital Market

  • News

    12 Health Care Stocks Moving In Thursday's Pre-Market Session

  • Press releasePRNewswire

    Syra Health Announces Second Quarter 2024 Financial Results, Led by Strong Revenue Growth of 101%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.